Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Study to Evaluate the Pharmacokinetics of Nemtabrutinib in Participants With Moderate Hepatic Impairment
The purpose of this study is to compare the plasma pharmacokinetics (PK) of nemtabrutinib (MK-1026) following a single oral dose of nemtabrutinib in participan…
Hepatic Impairment (HI)
Merck Sharp & Dohme LLCNCT06442436
Phase 1
A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics of a Single Oral Dose of EDG-7500 in Participants With Impaired and Normal Hepatic Function
The purpose of this Phase 1 study is to understand and compare the amount of EDG-7500 in the blood after a single dose in participants with different levels of…
Hepatic Impairment (HI)
Edgewise Therapeutics, Inc.NCT07324616